Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Carbone

Showing results (271-280 of 651) with videos related to

Pageof 66
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
New therapeutic approaches to low-grade B cell neoplasmsH I Robins, T E Davis, R A Steeves, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2001
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282R K Ramanathan, A Cnaan, R G Hahn, et al.
Cancer Treatment Reports|June 1, 1976
Clinical trials with BCNU (NSC-409962) in malignant lymphomas by the Eastern Cooperative Oncology GroupJ M Bennett, R F Bakemeier, P P Carbone, et al.
Cancer|April 1, 1974
Serum alpha-fetoprotein in 184 Ugandan patients with hepatocellular carcinoma. Clinical, laboratory, and histopathologic correlationsC L Vogel, A Primack, K R McIntire, et al.
JCO Precision Oncology|January 7, 2022
Pursuing Better Biomarkers for Immunotherapy Response in Cancer Through a Crowdsourced Data ChallengeBenjamin G Vincent, Joseph D Szustakowski, Parul Doshi, et al.
American Journal of Clinical Oncology|February 24, 2001
Reversible renal toxicity resulting from high single doses of the new radiosensitizer gadolinium texaphyrinD I Rosenthal, C R Becerra, R D Toto, et al.
Investigational New Drugs|July 30, 1999
PALA versus streptozotocin, doxorubicin, and MeCCNU in the treatment of patients with advanced pancreatic carcinomaR S Witte, L M Ryan, A J Schutt, et al.
Nature Genetics|June 1, 1996
A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancerH L Chen, D Gabrilovich, R Tampé, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|February 26, 2004
[Study of reproductive health risks in Sicily. Congenital malformations and exposure to EDCs: a case-control study (study methodology)]P Carbone, F Giordano, S Bianca, et al.
Cancer|December 1, 1991
Cancer control and the older person. Issues in treatmentL Balducci, T Ades, P P Carbone, et al.
Pageof 66

Showing results (271-280 of 651) with videos related to

Sort By:
Pageof 66
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
New therapeutic approaches to low-grade B cell neoplasmsH I Robins, T E Davis, R A Steeves, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2001
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282R K Ramanathan, A Cnaan, R G Hahn, et al.
Cancer Treatment Reports|June 1, 1976
Clinical trials with BCNU (NSC-409962) in malignant lymphomas by the Eastern Cooperative Oncology GroupJ M Bennett, R F Bakemeier, P P Carbone, et al.
Cancer|April 1, 1974
Serum alpha-fetoprotein in 184 Ugandan patients with hepatocellular carcinoma. Clinical, laboratory, and histopathologic correlationsC L Vogel, A Primack, K R McIntire, et al.
JCO Precision Oncology|January 7, 2022
Pursuing Better Biomarkers for Immunotherapy Response in Cancer Through a Crowdsourced Data ChallengeBenjamin G Vincent, Joseph D Szustakowski, Parul Doshi, et al.
American Journal of Clinical Oncology|February 24, 2001
Reversible renal toxicity resulting from high single doses of the new radiosensitizer gadolinium texaphyrinD I Rosenthal, C R Becerra, R D Toto, et al.
Investigational New Drugs|July 30, 1999
PALA versus streptozotocin, doxorubicin, and MeCCNU in the treatment of patients with advanced pancreatic carcinomaR S Witte, L M Ryan, A J Schutt, et al.
Nature Genetics|June 1, 1996
A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancerH L Chen, D Gabrilovich, R Tampé, et al.
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|February 26, 2004
[Study of reproductive health risks in Sicily. Congenital malformations and exposure to EDCs: a case-control study (study methodology)]P Carbone, F Giordano, S Bianca, et al.
Cancer|December 1, 1991
Cancer control and the older person. Issues in treatmentL Balducci, T Ades, P P Carbone, et al.
Pageof 66